Aptus Capital Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13M Buy
128,865
+1,000
+0.8% +$104K 0.09% 188
2026
Q1
$12.4M Buy
127,865
+1,190
+0.9% +$122K 0.1% 182
2025
Q4
$13.4M Buy
126,675
+526
+0.4% +$61K 0.1% 175
2025
Q3
$16M Buy
126,149
+16,594
+15% +$1.98M 0.12% 155
2025
Q2
$13.4M Buy
109,555
+9,727
+10% +$1.11M 0.11% 161
2025
Q1
$10.1M Buy
99,828
+11,132
+13% +$1.09M 0.1% 176
2024
Q4
$8.19M Buy
88,696
+16,410
+23% +$1.61M 0.09% 198
2024
Q3
$6.99M Buy
72,286
+10,022
+16% +$901K 0.1% 176
2024
Q2
$5.34M Buy
62,264
+12,375
+25% +$1.04M 0.09% 179
2024
Q1
$4.12M Buy
49,889
+5,280
+12% +$387K 0.08% 202
2023
Q4
$2.98M Sell
44,609
-545
-1% -$35.3K 0.08% 180
2023
Q3
$3.03M Sell
45,154
-9,198
-17% -$633K 0.08% 184
2023
Q2
$3.68M Buy
54,352
+4,233
+8% +$265K 0.09% 173
2023
Q1
$2.71M Buy
50,119
+5,872
+13% +$342K 0.07% 187
2022
Q4
$2.65M Buy
44,247
+4,712
+12% +$256K 0.08% 188
2022
Q3
$1.79M Buy
+39,535
New +$1.98M 0.04% 209
2021
Q4
Sell
-11,926
Closed -$712K 565
2021
Q3
$712K Sell
11,926
-11,932
-50% -$751K 0.02% 263
2021
Q2
$1.48M Buy
23,858
+3,595
+18% +$240K 0.04% 185
2021
Q1
$1.32M Buy
20,263
+3,922
+24% +$256K 0.05% 182
2020
Q4
$1.07M Buy
16,341
+2,615
+19% +$154K 0.05% 168
2020
Q3
$710K Sell
13,726
-327
-2% -$16.8K 0.04% 186
2020
Q2
$692K Buy
14,053
+163
+1% +$8.8K 0.04% 164
2020
Q1
$708K Buy
13,890
+981
+8% +$56.6K 0.06% 142
2019
Q4
$711K Buy
12,909
+2,124
+20% +$115K 0.05% 212
2019
Q3
$543K Sell
10,785
-2,755
-20% -$138K 0.03% 246
2019
Q2
$682K Buy
13,540
+6,321
+88% +$307K 0.1% 167
2019
Q1
$335K Buy
7,219
+3,092
+75% +$157K 0.06% 252
2018
Q4
$202K Buy
+4,127
New +$235K 0.05% 164

Other funds holding EHC

Aptus Capital Advisors's EHC Position: Q2 2026 in Review

Aptus Capital Advisors increased its Encompass Health (EHC) stake by 0.78% in Q2 2026, buying an estimated $104K and bringing the position to 128,865 shares worth $13M. The position accounts for 0.09% of the portfolio, ranked #188.

Aptus Capital Advisors first reported a position in EHC in Q4 2018 and has held it in 28 quarters since. The position peaked at $16M in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Aptus Capital Advisors held 128,865 shares of Encompass Health worth $13M as of Q2 2026.
  • Aptus Capital Advisors bought 1,000 Encompass Health shares in Q2 2026, an estimated $104K.
  • Encompass Health made up 0.09% of Aptus Capital Advisors's portfolio in Q2 2026, its #188 holding.
  • Aptus Capital Advisors first reported a position in Encompass Health in Q4 2018 and has held it in 28 quarters since.
  • Aptus Capital Advisors's Encompass Health position peaked at $16M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.